Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2017 $ 21,379,713 $ 50 $ 24,276 $ 117,827,839 $ (96,472,452)
Balance (in shares) at Dec. 31, 2017   49,626 24,276,275    
Cumulative Adj. - ASC 606 Adoption 81,724 $ 0 $ 0 0 81,724
Stock-Based Compensation Expense 424,700 $ 0 $ 6 424,694 0
Stock-Based Compensation Expense (in shares)   0 6,250    
Exercise of Warrants 39,375 $ 0 $ 25 39,350 0
Exercise of Warrants (in shares)   0 24,930    
Proceeds from Common Stock Offerings 30,000,000 $ 0 $ 3,000 29,997,000 0
Proceeds from Common Stock Offerings (in shares)   0 3,000,000    
Direct Costs of Common Stock Offerings (1,975,000) $ 0 $ 0 (1,975,000) 0
Net Loss (5,365,650) 0 0 0 (5,365,650)
Balance at Mar. 31, 2018 44,584,862 $ 50 $ 27,307 146,313,883 (101,756,378)
Balance (in shares) at Mar. 31, 2018   49,626 27,307,455    
Balance at Dec. 31, 2017 21,379,713 $ 50 $ 24,276 117,827,839 (96,472,452)
Balance (in shares) at Dec. 31, 2017   49,626 24,276,275    
Net Loss (21,875,713)        
Balance at Dec. 31, 2018 30,456,975 $ 50 $ 27,591 148,695,775 (118,266,441)
Balance (in shares) at Dec. 31, 2018   49,626 27,591,670    
Stock-Based Compensation Expense 413,686 $ 0 $ 7 413,679 0
Stock-Based Compensation Expense (in shares)   0 6,247    
Net Loss (6,359,761) $ 0 $ 0 0 (6,359,761)
Balance at Mar. 31, 2019 $ 24,510,900 $ 50 $ 27,598 $ 149,109,454 $ (124,626,202)
Balance (in shares) at Mar. 31, 2019   49,626 27,597,917